WASHINGTON (CN) – The Food and Drug Administration has changed its bottled water quality standards to establish an allowable level of 0.006 milligrams/liter for a certain phthalate.
Bottled water manufacturers will be required to monitor their finished bottled water products for the chemical di(2-ethylhexyl)phthalate (DEHP) at least once a year, under the current good manufacturing practice (CGMP) regulations for bottled water.
In response to a public comment, the FDA stated that the prior sanction for the use of DEHP in a section of its rules does not preclude the agency from establishing an allowable level for DEHP in the bottled water quality standard under a different section.
The FDA pointed out that it has not changed rules about phthalates in plastic water bottles.
Bottled water manufacturers also will be required to monitor their source water for DEHP as often as necessary, but at least once a year, unless they meet the criteria for source water monitoring exemptions under the CGMP regulations.
Click the document icon for this regulation and others.